首页> 外国专利> METHOD FOR PREDICTING THE EFFICIENCY OF TREATMENT OF HEPATITIS C WITH THE CHILDREN OF THE FIRST YEAR OF LIFE

METHOD FOR PREDICTING THE EFFICIENCY OF TREATMENT OF HEPATITIS C WITH THE CHILDREN OF THE FIRST YEAR OF LIFE

机译:预测第一年生儿童肝炎C疗效的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to clinical laboratory medicine, and concerns the method for predicting the effectiveness of treatment of hepatitis C in children of first year of life. Practice essentials: before starting the antiviral therapy in a child polymorphism of genes is determined, coding IL28 (γIFN) rs809917 and rs12979860, and in the presence of: - homozygous forms [TT] for the gene rs809917 and [CC] for the gene rs12979860 - prognosis is laudable, - forms [TG] or [GG] for the gene rs809917 and [TT] or [CT] gene rs12979860 - unfavorable prognosis .MEthod allows in advance, prior to treatment, to adjust therapy, to predict its effectiveness and, thus, to identify a group of children, for that therapy is strictly indicated because of the very high chance of a cure before the onset of complications, and a group for that the chance for success of the therapy is minimal, and, taking into consideration the duration and relative cost of drugs in case of absence of efficacy, treatment is not advisable.;EFFECT: proposed method is simple and can be widely used in clinical practice in hospitals and diagnostic centers.;1 cl, 2 dwg, 2 ex
机译:药物发明领域本发明涉及药物,即临床检验医学,并且涉及预测在第一岁的儿童中丙型肝炎的治疗效果的方法。实践要点:在开始抗病毒治疗之前,先确定儿童的基因多态性,其编码IL28(γIFN)rs809917和rs12979860,并且在以下情况下存在:-基因rs809917的纯合型[TT]和基因rs12979860的[CC] -预后值得赞扬-rs809917基因和[TT]或[CT]基因rs12979860基因形成[TG]或[GG]-预后不良。MEthod允许在治疗前预先调整治疗方案,预测其疗效和因此,为了确定一组儿童,由于在并发症发作之前有很高的治愈机会,因此严格指示该疗法;而对于一组儿童,该疗法成功的机会极小,并且考虑到考虑到在没有疗效的情况下药物的持续时间和相对成本,不建议治疗。效果:建议的方法简单,可广泛用于医院和诊断中心的临床实践。1cl,2 dwg,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号